Altimmune Announces Stockholder Voting Results from 2024 Annual Meeting

Altimmune, Inc.

All seven director nominees were elected, with Mitchel Sayare receiving 21,231,279 votes for and 660,730 withheld, and broker non-votes of 21,784,295.
Ratification of Ernst & Young as auditor passed with 43,204,496 votes for, 315,411 against.
Advisory say-on-pay proposal passed with 13,663,909 votes for, 7,992,177 against, and 21,784,295 broker non-votes.
Proposal to authorize adjournment for proxy solicitation passed with 26,771,350 votes for, 16,249,120 against.
Total shares voted: 43,676,304 out of 71,070,951 outstanding, representing 61.5% quorum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.